On the public citation graph
Risk of cardiovascular disease and loss in life expectancy in NAFLD
0 signed · 100 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1001/jama.288.21.2709openalex-snapshot
The Metabolic Syndrome and Total and Cardiovascular Disease Mortality in Middle-aged Men
inferredcites →https://doi.org/10.1002/hep.23314openalex-snapshot
Decreased Survival of Subjects With Elevated Liver Function Tests During A 28-Year Follow-Up
inferredcites →https://doi.org/10.1002/hep.26156openalex-snapshot
Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States
inferredcites →https://doi.org/10.1002/hep.27368openalex-snapshot
Fibrosis stage is the strongest predictor for disease‐specific mortality in NAFLD after up to 33 years of follow‐up
inferredcites →https://doi.org/10.1002/hep.27598openalex-snapshot
The clinical course of cirrhosis: The importance of multistate models and competing risks analysis
inferredcites →https://doi.org/10.1002/hep.29546openalex-snapshot
Nonalcoholic fatty liver disease incidence and impact on metabolic burden and death: A 20 year‐community study
inferredcites →https://doi.org/10.1002/hep.30251openalex-snapshot
Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
inferredcites →https://doi.org/10.1002/hep.31726openalex-snapshot
Administrative Coding in Electronic Health Care Record‐Based Research of NAFLD: An Expert Panel Consensus Statement
inferredcites →https://doi.org/10.1002/hep.32519openalex-snapshot
Risk of cardiovascular disease and loss in life expectancy in NAFLD
inferredcites →https://doi.org/10.1002/sim.2712openalex-snapshot
Tutorial in biostatistics: competing risks and multi‐state models
inferredcites →https://doi.org/10.1002/sim.3064openalex-snapshot
Flexible parametric models for relative survival, with application in coronary heart disease
inferredcites →https://doi.org/10.1002/sim.5943openalex-snapshot
Estimating the loss in expectation of life due to cancer using flexible parametric survival models
inferredcites →https://doi.org/10.1007/s10654-016-0117-yopenalex-snapshot
Registers of the Swedish total population and their use in medical research
inferredcites →https://doi.org/10.1007/s10654-017-0316-1openalex-snapshot
The Swedish cause of death register
inferredcites →https://doi.org/10.1016/j.jhep.2016.05.013openalex-snapshot
Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis
inferredcites →https://doi.org/10.1016/j.jhep.2019.06.021openalex-snapshot
The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: A systematic review and meta-analysis
inferredcites →https://doi.org/10.1016/s2468-1253(21)00308-3openalex-snapshot
Non-alcoholic fatty liver disease and risk of fatal and non-fatal cardiovascular events: an updated systematic review and meta-analysis
inferredcites →https://doi.org/10.1053/j.gastro.2020.01.043openalex-snapshot
Association Between Fibrosis Stage and Outcomes of Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis
inferredcites →https://doi.org/10.1080/00365521.2020.1820566openalex-snapshot
Validity of administrative codes associated with cirrhosis in Sweden
inferredcites →https://doi.org/10.1097/meg.0000000000001075openalex-snapshot
Synergistic increase in cardiovascular risk in diabetes mellitus with nonalcoholic fatty liver disease: a meta-analysis
inferredcites →https://doi.org/10.1111/j.1478-3231.2004.0969.xopenalex-snapshot
Non‐alcoholic fatty liver disease – a common and benign finding in octogenarian patients
inferredcites →https://doi.org/10.1111/j.1572-0241.2008.02034.xopenalex-snapshot
Suspected Nonalcoholic Fatty Liver Disease and Mortality Risk in a Population-Based Cohort Study
inferredcites →https://doi.org/10.1111/joim.13343openalex-snapshot
Risk for hepatic and extra‐hepatic outcomes in nonalcoholic fatty liver disease
inferredcites →https://doi.org/10.1111/liv.13973openalex-snapshot
Cardiovascular risk factors in non‐alcoholic fatty liver disease
inferredcites →https://doi.org/10.1136/bmj.d6891openalex-snapshot
Non-alcoholic fatty liver disease and mortality among US adults: prospective cohort study
inferredcites →https://doi.org/10.1136/bmj.l5367openalex-snapshot
Non-alcoholic fatty liver disease and risk of incident acute myocardial infarction and stroke: findings from matched cohort study of 18 million European adults
inferredcites →https://doi.org/10.1136/gutjnl-2020-320622openalex-snapshot
NAFLD and increased risk of cardiovascular disease: clinical associations, pathophysiological mechanisms and pharmacological implications
inferredcites →https://doi.org/10.1136/gutjnl-2021-325724openalex-snapshot
Non-alcoholic fatty liver disease and incident major adverse cardiovascular events: results from a nationwide histology cohort
inferredcites →https://doi.org/10.1177/1536867x0900900206openalex-snapshot
Further Development of Flexible Parametric Models for Survival Analysis
inferredcites →https://doi.org/10.1186/1471-2458-11-450openalex-snapshot
External review and validation of the Swedish national inpatient register
inferredcites →https://doi.org/10.1210/jc.2007-0482openalex-snapshot
Liver Fat in the Metabolic Syndrome
inferredcites →https://doi.org/10.14309/ajg.0000000000000401openalex-snapshot
Women With Nonalcoholic Fatty Liver Disease Lose Protection Against Cardiovascular Disease: A Longitudinal Cohort Study
inferredcites →https://doi.org/10.7326/m16-2607openalex-snapshot
Sensitivity Analysis in Observational Research: Introducing the E-Value
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.2139/ssrn.4826078openalex-extracted
Liver Stiffness, Liver Function and Subsequent Metabolic Syndrome in NAFLD Associated Subclinical Atherosclerosis: Perspective from Mediation Analysis
inferred← citeshttps://doi.org/10.1002/hep.32635openalex-snapshot
Fatty liver disease is not associated with increased mortality in the elderly: A prospective cohort study
inferred← citeshttps://doi.org/10.1002/hep.32652openalex-snapshot
Less is more? Screening for steatosis in older populations
inferred← citeshttps://doi.org/10.1007/s00125-026-06761-yopenalex-snapshot
MASLD, diabetes and PMOS across the female life stages
inferred← citeshttps://doi.org/10.1007/s10620-026-10033-5openalex-snapshot
Incidence of Cardiovascular Events and Extrahepatic Malignancies in Steatotic Liver Disease Subgroups
inferred← citeshttps://doi.org/10.1007/s11357-024-01435-2openalex-snapshot
Associations between MASLD, atrial fibrillation, cardiovascular events, mortality and aspirin use in older adults
inferred← citeshttps://doi.org/10.1007/s11886-024-02185-5openalex-snapshot
Cardiovascular Risk Reduction in Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis
inferred← citeshttps://doi.org/10.1007/s12072-023-10590-1openalex-snapshot
How non-alcoholic fatty liver disease and cirrhosis affect the heart
inferred← citeshttps://doi.org/10.1016/j.biopha.2024.117067openalex-snapshot
Pemafibrate abrogates SLD in a rat experimental dietary model, inducing a shift in fecal bile acids and microbiota composition
inferred← citeshttps://doi.org/10.1016/j.carres.2025.109695openalex-snapshot
Structural characterization, in vitro antioxidant and lipid-lowering activities of purified polysaccharides from hawthorn leaf
inferred← citeshttps://doi.org/10.1016/j.cgh.2023.09.018openalex-snapshot
Longitudinal Outcomes Associated With Metabolic Dysfunction-Associated Steatotic Liver Disease: A Meta-analysis of 129 Studies
inferred← citeshttps://doi.org/10.1016/j.clinre.2026.102853openalex-snapshot
Impact of metabolic liver disease on colorectal cancer and liver metastases: Pathophysiology and implications for hepatobiliary surgery
inferred← citeshttps://doi.org/10.1016/j.ejim.2023.11.012openalex-snapshot
Management of cardiovascular risk in patients with metabolic dysfunction-associated steatotic liver disease
inferred← citeshttps://doi.org/10.1016/j.eprac.2022.10.007openalex-snapshot
A Meta-analysis on Associated Risk of Mortality in Nonalcoholic Fatty Liver Disease
inferred← citeshttps://doi.org/10.1016/j.gastre.2025.502442openalex-snapshot
Multidisciplinary clinical practice guideline on the management of metabolic hepatic steatosis
inferred← citeshttps://doi.org/10.1016/j.gastre.2026.502639openalex-snapshot
Corrigendum. Multidisciplinary clinical practice guideline on the management of metabolic hepatic steatosis
inferred← citeshttps://doi.org/10.1016/j.gastrohep.2025.502442openalex-snapshot
Guía de práctica clínica multidisciplinar de manejo de la esteatosis hepática metabólica
inferred← citeshttps://doi.org/10.1016/j.gastrohep.2025.502639openalex-snapshot
Corrigendum. Guía de práctica clínica multidisciplinar de manejo de la esteatosis hepática metabólica
inferred← citeshttps://doi.org/10.1016/j.jacc.2025.08.100openalex-snapshot
The Basics of Metabolic Dysfunction–Associated Steatotic Liver Disease for Cardiologists
inferred← citeshttps://doi.org/10.1016/j.jhep.2023.04.036openalex-snapshot
Changing epidemiology, global trends and implications for outcomes of NAFLD
inferred← citeshttps://doi.org/10.1016/j.jhep.2025.03.001openalex-snapshot
Cause-specific mortality in 13,099 patients with metabolic dysfunction-associated steatotic liver disease in Sweden
inferred← citeshttps://doi.org/10.1016/j.numecd.2023.01.013openalex-snapshot
Comparison of cardiovascular mortality between MAFLD and NAFLD: A cohort study
inferred← citeshttps://doi.org/10.1016/j.numecd.2023.03.003openalex-snapshot
Sex differences in cardiovascular and all-cause mortality in nonalcoholic fatty liver disease in the US population
inferred← citeshttps://doi.org/10.1016/s1875-5364(24)60690-4openalex-snapshot
Emerging mechanisms of non-alcoholic steatohepatitis and novel drug therapies
inferred← citeshttps://doi.org/10.1016/s2468-1253(24)00193-6openalex-snapshot
Natural history and progression of metabolic dysfunction-associated steatotic liver disease
inferred← citeshttps://doi.org/10.1038/s41467-024-46686-xopenalex-snapshot
Elevated blood remnant cholesterol and triglycerides are causally related to the risks of cardiometabolic multimorbidity
inferred← citeshttps://doi.org/10.1038/s41467-024-47919-9openalex-snapshot
The pan-PPAR agonist lanifibranor improves cardiometabolic health in patients with metabolic dysfunction-associated steatohepatitis
inferred← citeshttps://doi.org/10.1038/s42255-025-01394-8openalex-snapshot
Human genetics of steatotic liver disease: insights into insulin resistance and lipid metabolism
inferred← citeshttps://doi.org/10.1038/s43856-025-00871-1openalex-snapshot
The importance of patient engagement in the multimodal treatment of MASLD
inferred← citeshttps://doi.org/10.1038/s43856-025-01220-yopenalex-snapshot
Whole-genome profiling of age- and sex-associated DNA methylation signatures in human plasma cell-free DNA
inferred← citeshttps://doi.org/10.1080/00365521.2023.2185475openalex-snapshot
Administrative coding for non-alcoholic fatty liver disease is accurate in Swedish patients
inferred← citeshttps://doi.org/10.1080/00365521.2025.2536585openalex-snapshot
Cardiovascular implications of MASLD: overview of the evidence
inferred← citeshttps://doi.org/10.1093/eurjpc/zwae306openalex-snapshot
Cardiovascular disease and metabolic dysfunction-associated steatotic liver disease: pathophysiology and diagnostic aspects
inferred← citeshttps://doi.org/10.1093/postmj/qgae025openalex-snapshot
Sigmoidal relationship between liver fat content and nonalcoholic fatty liver disease in Chinese adults
inferred← citeshttps://doi.org/10.1096/fj.202503210ropenalex-snapshot
Interaction Between Photoperiod and Sex on Hepatic Lipid Homeostasis in Rats Fed an Obesogenic Diet
inferred← citeshttps://doi.org/10.1097/hc9.0000000000000075openalex-snapshot
The Steatosis-associated fibrosis estimator (SAFE) score: validation in the general US population
inferred← citeshttps://doi.org/10.1097/hc9.0000000000000756openalex-snapshot
Prevalence and outcomes of steatotic liver disease subtypes in older adults
inferred← citeshttps://doi.org/10.1097/hep.0000000000000023openalex-snapshot
CAP and LSM as determined by VCTE are independent predictors of all-cause mortality in the US adult population
inferred← citeshttps://doi.org/10.1097/hep.0000000000000263openalex-snapshot
Diabetes and cirrhosis: Current concepts on diagnosis and management
inferred← citeshttps://doi.org/10.1097/hep.0000000000001066openalex-snapshot
A functional genomic framework to elucidate novel causal metabolic dysfunction–associated fatty liver disease genes
inferred← citeshttps://doi.org/10.1111/dom.16568openalex-snapshot
Metabolic dysfunction‐associated steatotic liver disease and sex‐specific risk of fatal and non‐fatal cardiovascular events: A meta‐analysis
inferred← citeshttps://doi.org/10.1111/liv.15680openalex-snapshot
Risk of infections in non‐alcoholic fatty liver disease: A nationwide population‐based cohort study
inferred← citeshttps://doi.org/10.1111/liv.15725openalex-snapshot
Metabolic dysfunction‐associated steatotic liver disease in older adults is associated with frailty and social disadvantage
inferred← citeshttps://doi.org/10.1111/liv.15910openalex-snapshot
Sex differences in mortality and liver‐related events in non‐alcoholic fatty liver disease: A systematic review and meta‐analysis
inferred← citeshttps://doi.org/10.1136/bmjgast-2022-000951openalex-snapshot
Prevalence of frailty in patients with non-cirrhotic non-alcoholic fatty liver disease
inferred← citeshttps://doi.org/10.1136/bmjph-2025-003322openalex-snapshot
Temporal comorbidity patterns preceding MASLD-related major adverse liver outcomes: a nationwide population-based case–control study in Sweden
inferred← citeshttps://doi.org/10.1186/s12876-025-03876-1openalex-snapshot
The association between modified cardiometabolic index with non-alcoholic fatty liver disease and liver fibrosis: a cross-sectional study
inferred← citeshttps://doi.org/10.1186/s12933-026-03097-0openalex-snapshot
Cohort profile: The DIabetes and ST-segment Elevation Myocardial Infarction (DISTEMI) Study
inferred← citeshttps://doi.org/10.1186/s13098-025-01870-xopenalex-snapshot
Systemic evaluation of the effects of monomeric GLP-1R-based agonists on MASLD and its complications
inferred← citeshttps://doi.org/10.1186/s13765-022-00745-3openalex-snapshot
Extraction of raspberry ketone from red raspberry and its intervention in the non-alcoholic fatty liver disease
inferred← citeshttps://doi.org/10.1210/clinem/dgaf593openalex-snapshot
Diurnal Light Exposure and Rest-Activity Rhythms in Relation to MASLD: Insights From 2 Nationwide Cohort Studies
inferred← citeshttps://doi.org/10.14309/ajg.0000000000002760openalex-snapshot
Impact of HIV Infection on Liver and Cardiovascular Outcomes in Veterans With Metabolic Dysfunction-Associated Steatotic Liver Disease
inferred← citeshttps://doi.org/10.15420/ecr.2023.34openalex-snapshot
Treatment Options and Continuity of Care in Metabolic-associated Fatty Liver Disease: A Multidisciplinary Approach
inferred← citeshttps://doi.org/10.20517/mtod.2024.129openalex-snapshot
Shared genetic architecture between metabolic dysfunction-associated steatotic liver disease and cardiometabolic traits comorbidities: a genome-wide pleiotropic and multi-omics study
inferred← citeshttps://doi.org/10.2147/dmso.s426102openalex-snapshot
Liver Fibrosis Scores and Coronary Artery Disease: Novel Findings in Patients with Metabolic Dysfunction-Associated Fatty Liver Disease
inferred← citeshttps://doi.org/10.22416/1382-4376-2025-35-3-104-113openalex-snapshot
The Impact of Menopausal Hormone Therapy on Liver and Biliary Tract Health
inferred← citeshttps://doi.org/10.3389/fmed.2024.1384366openalex-snapshot
The relationship between muscle mass and fat content in body composition and non-alcoholic fatty liver disease in the Chinese general population: a cross-sectional study
inferred← citeshttps://doi.org/10.3389/fnut.2026.1817870openalex-snapshot
Dietary Inflammatory Index and risk of nonalcoholic fatty liver disease: nonlinear associations, metabolic mediation, and external validation
inferred← citeshttps://doi.org/10.3390/antiox14010056openalex-snapshot
Gut Microbiota at the Crossroad of Hepatic Oxidative Stress and MASLD
inferred← citeshttps://doi.org/10.3390/biomedicines13081977openalex-snapshot
Genetic Variants, Metabolic Dysfunction-Associated Fatty Liver Disease, and Major Health Outcomes in Older Adults
inferred← citeshttps://doi.org/10.3390/diagnostics12102336openalex-snapshot
Liver Stiffness Is Associated with the Burden of Carotid and Systemic Atherosclerosis in an Unorganized Cohort of Patients 40–64 Years Old
inferred← citeshttps://doi.org/10.3390/life15101523openalex-snapshot
Therapeutic Potential of Quercetin, Silibinin, and Crocetin in a High-Fat Diet-Induced Mouse Model of MASLD: The Role of CD36 and PLIN3
inferred← citeshttps://doi.org/10.3390/molecules31142466openalex-snapshot
Cyclodipeptides Reversed Liver Damage and Adipose Tissue Dysfunction in a Chronic Obesity MASLD Rat Model by Remodeling White Adipocytes Toward a Beige-like Adipocyte Phenotype
inferred← citeshttps://doi.org/10.3390/nu15132954openalex-snapshot
Intragastric Safflower Yellow Alleviates HFD Induced Metabolic Dysfunction-Associated Fatty Liver Disease in Mice through Regulating Gut Microbiota and Liver Endoplasmic Reticulum Stress
inferred← citeshttps://doi.org/10.47102/annals-acadmedsg.2022284openalex-snapshot
Non-alcoholic fatty liver disease screening in type 2 diabetes mellitus: A cost-effectiveness and price threshold analysis
inferred← citeshttps://doi.org/10.61838/kman.hn.2.2.7openalex-snapshot
The Effectiveness of Acceptance and Commitment Therapy on Psychological Well-being, Resilience, and Hope for Life in Coronary Heart Disease Patients with High Blood Pressure Visiting Shahid Rajaei Hospital
showing the first 66 of 67 · page through all 67
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.